Humana Inc (HUM) shares are moving today on volatility 0.36% or $0.86 from the open. The NYSE listed company saw a recent bid of 241.35 and 118796 shares have traded hands in the session.
Investors may be taking a look at certain business aspects when attempting to research a stock. Investors often look to see if the stock’s specific industry is on the rise. There may be a greater chance of success when investing in an industry that is rapidly growing. Investors may then want to see how the company stacks up within the industry. Many investors will look for stocks that are proven industry leaders. Industry leaders have the ability to influence pricing and not necessarily be susceptible to what other companies are doing around them. Investors may also be taking note of how a company invests in research and development. Companies that are focused on the future may have a competitive advantage over those who are too focused on the near-term.
Now let’s take a look at how the fundamentals are stacking up for Humana Inc (HUM). Fundamental analysis takes into consideration market, industry and stock conditions to help determine if the shares are correctly valued. Humana Inc currently has a yearly EPS of 12.16. This number is derived from the total net income divided by shares outstanding. In other words, EPS reveals how profitable a company is on a share owner basis.
Turning to Return on Assets or ROA, Humana Inc (HUM) has a current ROA of 2.41. This is a profitability ratio that measures net income generated from total company assets during a given period. This ratio reveals how quick a company can turn it’s assets into profits. In other words, the ratio provides insight into the profitability of a firm’s assets. The ratio is calculated by dividing total net income by the average total assets. A higher ROA compared to peers in the same industry, would suggest that company management is able to effectively generate profits from their assets. Similar to the other ratios, a lower number might raise red flags about management’s ability when compared to other companies in a similar sector.
Another key indicator that can help investors determine if a stock might be a quality investment is the Return on Equity or ROE. Humana Inc (HUM) currently has Return on Equity of 5.84. ROE is a ratio that measures profits generated from the investments received from shareholders. In other words, the ratio reveals how effective the firm is at turning shareholder investment into company profits. A company with high ROE typically reflects well on management and how well a company is run at a high level. A firm with a lower ROE might encourage potential investors to dig further to see why profits aren’t being generated from shareholder money.
Another ratio we can look at is the Return on Invested Capital or more commonly referred to as ROIC. Humana Inc (HUM) has a current ROIC of 4.29. ROIC is calculated by dividing Net Income – Dividends by Total Capital Invested.
Similar to ROE, ROIC measures how effectively company management is using invested capital to generate company income. A high ROIC number typically reflects positively on company management while a low number typically reflects the opposite.
Figuring out when to sell a stock can be just as important as deciding what stocks to buy at the outset. Some investors may refuse to sell based on various factors. Investors may have become stubborn, too emotionally attached, or set too high of an expectation for a stock. Holding on to a stock for way too long in order to squeeze every last drop of profit out of a price move may leave the investor desperately searching for answers in the future. Investors may have different checklists for when it is time to sell a stock. Of course this depends largely on the individual and how much is at risk. Often times, investors will make a move to sell when the fundamentals drastically change, the dividend is cut, or a previous set target price has been hit. Getting out of a position at the right time is obviously not easy, but it may become a bit easier with time and research.